Hanmi Science Co (008930.KS) Stock Price
Hanmi Science Co Price
Hanmi Science Co (008930.KS) Stock | ISIN KR7008930000. The current Hanmi Science Co stock price is 30,750 KRW (2026). Market capitalization is 2.08 T KRW. Hanmi Science Co operates in the Health sector.
Revenue has compounded at 6.4% per year over the past 19 years to 1.28 T KRW. Earnings per share have declined at 5% per year over the last 19 years. Hanmi Science Co's net margin stands at 4.6%, up from 2.6% several years earlier. Hanmi Science Co currently offers a dividend yield of about 0.98%. The payout ratio is around 28% of earnings.
Hanmi Science Co stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Hanmi Science Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Hanmi Science Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Hanmi Science Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Hanmi Science Co Price |
|---|
Hanmi Science Co Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Hanmi Science Co Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (T KRW) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B KRW) |
| NET INCOME (B KRW) |
| NET INCOME GROWTH (%) |
| DIVIDEND (KRW)DIV. (KRW) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| 0.65 | 0.71 | 0.82 | 0.86 | 0.95 | 1.05 | 1.25 | 1.28 |
| -1.95 | 8.53 | 15.34 | 4.99 | 10.82 | 10.09 | 19.3 | 2.85 |
| 14.05 | 13.05 | 13.27 | 14.08 | 13.97 | 15.33 | 18.88 | 18.9 |
| 91.64 | 92.41 | 108.33 | 120.72 | 132.77 | 160.37 | 235.59 | 242.61 |
| 30.07 | 18.02 | 30.74 | 22.6 | 42.94 | 69.21 | 115.12 | 59.42 |
| 278.8 | -40.07 | 70.6 | -26.48 | 90 | 61.17 | 66.34 | -48.38 |
| 196.08 | 196.08 | 200 | 196.08 | 196.08 | 196.08 | 200 | 300 |
| -52.74 | – | 2 | -1.96 | – | – | 2 | 50 |
| 64 | 66 | 66 | 66 | 68.62 | 68.49 | 67.96 | 67.72 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Hanmi Science Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Hanmi Science Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Hanmi Science Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Hanmi Science Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Hanmi Science Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Hanmi Science Co stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Hanmi Science Co Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Hanmi Science Co business model & stock analysis
Hanmi Science Co SWOT Analysis
Strengths
Hanmi Science Co Ltd has a strong emphasis on research and development, allowing them to continuously innovate and develop new products. This gives them a competitive advantage in the market and enables them to meet the evolving needs of their customers.
The company offers a wide range of products in various therapeutic areas, including pharmaceuticals, vaccines, and medical devices. This diversified portfolio helps them cater to different customer segments and provides stability in their revenue streams.
Hanmi Science Co Ltd has established a strong market presence, both domestically and internationally. Their products are well-regarded, and they have built a reputation for quality and reliability. This helps them attract and retain customers, as well as forge strategic partnerships.
Weaknesses
While Hanmi Science Co Ltd has a robust product portfolio, they still rely heavily on a limited number of key products for a significant portion of their revenues. This makes them vulnerable to market fluctuations and increased competition in those specific product categories.
Compared to some of their larger competitors, Hanmi Science Co Ltd has a relatively small market share. This can limit their bargaining power with suppliers and customers, as well as hinder their ability to invest in new technologies or expand their market reach.
Opportunities
The company has an opportunity to expand its presence in emerging markets, where there is a growing demand for healthcare products. Additionally, exploring international markets further can help Hanmi Science Co Ltd tap into new customer bases, diversify their revenue streams, and reduce dependence on any one market.
Forming strategic partnerships and collaborations with other pharmaceutical companies or research institutions can provide Hanmi Science Co Ltd with access to new technologies, resources, and markets. These alliances can accelerate their product development process and enable them to stay ahead of competitors.
Threats
The pharmaceutical and healthcare industry is highly competitive, with numerous players vying for market share. Hanmi Science Co Ltd faces competition from both domestic and international companies, which can pose a threat to their market position and profitability.
Operating in the pharmaceutical sector involves stringent regulations and compliance requirements. Changes in government policies, pricing regulations, or delays in product approvals can create challenges for Hanmi Science Co Ltd, impacting their ability to bring new products to the market and affecting their revenue streams.
Rapid advancements in technology and the emergence of alternative treatment options can pose a threat to traditional pharmaceutical companies like Hanmi Science Co Ltd. They need to stay updated with the latest trends and invest in research to ensure their products remain relevant and competitive in the market.
Hanmi Science Co Eulerpool Fair Value
Hanmi Science Co historical P/E ratio, EBIT multiple, and P/S ratio
Hanmi Science Co annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Hanmi Science Co shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Hanmi Science Co Dividend History
26 years of dividend payments · 2 consecutive increases
Hanmi Science Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
EESG©
Eulerpool ESG Scorecard© for the Hanmi Science Co stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Hanmi Science Co shareholder structure
| % | Name |
|---|---|
16.5985% | |
9.90982% | |
7.64374% | |
7.02122% | |
6.77529% | |
6.19359% | |
5.14478% | |
3.41541% | |
3.10297% | |
3.04665% |
Hanmi Science Co Executives and Management Board
Ms. Ju Hyeon Yim
(49)Co-President, Director · since 2009
Mr. Jong Yun Yim
(51)Co-President, Director · since 2009
Mr. Jong Hun Yim
(46)Chief Executive Officer, Director · since 2009
Mr. Seong Jae Shin
(58)Managing Director
Mr. Chang Ju Choi
(50)Assistant Managing Director
Hanmi Science Co Supply Chain
Frequently asked questions about Hanmi Science Co
The business model of Hanmi Science Co Ltd., a South Korean company, revolves around its expertise in the field of biotechnology. Hanmi Science focuses on the development, manufacturing, and distribution of innovative pharmaceutical products. The company is committed to researching and creating cutting-edge drugs and therapies to address various medical conditions and improve patient outcomes. With a strong emphasis on research and development, Hanmi Science aims to enhance global healthcare by delivering novel treatment options to customers worldwide.
Hanmi Science Co stock
Hanmi Science Co Peer Group
Hanmi Science Co Ticker
Hanmi Science Co FIGI
All fundamentals and in-depth analysis of Hanmi Science Co
Our stock analysis for Hanmi Science Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hanmi Science Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.